Aryl sulfonamides and sulfamide derivatives and uses thereof
US6211241A · kind A · utility
22Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Jun 1, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is directed to novel aryl sulfonamide and sulfamide compounds which bind selectively to and inhibit the activity of the human Y5 receptor. This invention is also related to uses of these compounds for the treatment of feeding disorders such as obesity, anorexia nervosa, bulimia nervosa, and abnormal conditions such as sexual/reproductive disorders, depression, epileptic seizure, hypertension, cerebral hemorrhage, congestive heart failure or sleep disturbances and for the treatment of any disease in which antagonism of a Y5 receptor may be useful.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.